| Condition or disease | Intervention/treatment |
|---|---|
| Acute Coronary Syndrome Unstable Angina Pectoris Myocardial Infarction Coronary Disease | Other: Non-interventional patient registry |
Show detailed description
| Study Type : | Observational |
| Estimated Enrollment : | 130000 participants |
| Observational Model: | Cohort |
| Time Perspective: | Other |
| Official Title: | The International Survey of Acute Coronary Syndromes- ARCHIVES |
| Actual Study Start Date : | June 28, 2019 |
| Estimated Primary Completion Date : | June 28, 2022 |
| Estimated Study Completion Date : | June 28, 2022 |
| Group/Cohort | Intervention/treatment |
|---|---|
| Male |
Other: Non-interventional patient registry
Non-interventional patient registry
|
| Female |
Other: Non-interventional patient registry
Non-interventional patient registry
|
| Kidney Disease |
Other: Non-interventional patient registry
Non-interventional patient registry
|
| Diabetes |
Other: Non-interventional patient registry
Non-interventional patient registry
|
| Elderly |
Other: Non-interventional patient registry
Non-interventional patient registry
|
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
| Contact: Raffaele Bugiardini, MD | +39 335 5612962 | raffaele.bugiardini@unibo.it |
| Italy | |
| University of Bologna | Recruiting |
| Bologna, Italy, 40138 | |
| Contact: Raffaele Bugiardini, MD +393355612962 raffaele.bugiardini@unibo.it | |
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Submitted Date | June 28, 2019 | ||||
| First Posted Date | July 5, 2019 | ||||
| Last Update Posted Date | September 7, 2020 | ||||
| Actual Study Start Date | June 28, 2019 | ||||
| Estimated Primary Completion Date | June 28, 2022 (Final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures |
|
||||
| Original Primary Outcome Measures | Same as current | ||||
| Change History | |||||
| Current Secondary Outcome Measures |
|
||||
| Original Secondary Outcome Measures |
|
||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title | The International Survey of Acute Coronary Syndromes-ARCHIVES | ||||
| Official Title | The International Survey of Acute Coronary Syndromes- ARCHIVES | ||||
| Brief Summary | ISACS ARCHIVES network is part of ISACS TC (NCT01218776) health care program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The ISACS ARCHIVES network assists health care providers, scientists, and policymakers seeking unbiased information about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services, particularly prescription medications and medical devices in acute coronary syndromes (ACS). | ||||
| Detailed Description |
Purpose ISACS-TC investigators may deposit to the ISACS ARCHIVES their registry data acquired prior to the first submitted date of ISACS-TC at ClinicalTrials.gov (October 7, 2010). Non- ISACS investigators with ACS data are welcome to deposit their data to the ISACS ARCHIVES as well. In this case the data may have been acquired prior or later than October 7, 2010. The data in the ISACS ARCHIVES will be catalogued and made available to the general research community. The ISACS ARCHIVES will use an established informatics infrastructure, hosted and managed by the ISACS TC (NCT01218776) and the Department of Electrical and Computer Engineering, University of California, Los Angeles, California, which will enable the sharing and use of data. The NIH. Gov. Registration number for the ISACS ARCHIVES will serve as the key for ACS related data submissions to the contact persons. Applicable Data The ISACS ARCHIVES will accept only de-identified data from human subjects' studies on ACS (for a definition of human subjects see: https://humansubjects.nih.gov/glossary). This will include data from clinical trials, epidemiological surveys, and other types of studies involving human subjects. Databases with significant genomic data (e.g., genome-wide association studies, medical sequencing, molecular diagnostic assays), are expected to be deposited as well. Likewise, physical bio-samples can be included in the ISACS ARCHIVES. Data Sharing Procedures Data submitted to the ISACS ARCHIVES must be de-identified by the investigator prior to submission. Submitted data will be subjected to algorithms that check for basic data accuracy. Any problematic data items will be summarized in a report and returned to the investigator for corrective action, if necessary, before data are accepted. Data will be made available for sharing with general research community 2 months after the deposit. This 2-month embargo period will provide study investigators with protected time to check for basic data accuracy. After the embargo, the data will be made available for sharing with the general research community. Investigators will be able to gain access to ISACS ARCHIVES data by submitting a data access request to ISACS TC (NCT01218776) contact persons. Data requests will be reviewed by an ISACS ARCHIVES Data Access Committee. The Department of Electrical and Computer Engineering, University of California, Los Angeles, California will collect data. ISACS Data Archive Sharing The following is a summary of tasks and expectations related to submitting data to the ISACS ARCHIVES. The purpose of this summary is to provide an overview of data submission and data sharing via the ISACS ARCHIVES. This list only provides a summary of tasks. Investigators are expected to:
Policy Implementation ISACS ARCHIVES expects investigators and their institutions to provide basic plans for policy implementation At present PI Study Investigators:
ISACS ARCHIVES Data Access Committee
ISACS ARCHIVES Data Sharing Coordinators
Sponsor University of Bologna Inquiries Please direct all inquiries to: Principal Investigator: Raffaele Bugiardini, MD University of Bologna |
||||
| Study Type | Observational | ||||
| Study Design | Observational Model: Cohort Time Perspective: Other |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples With DNA Description:
Databases with significant genomic data (e.g., genome-wide association studies, medical sequencing, molecular diagnostic assays), are expected to be deposited as well. Likewise, physical bio-samples can be included in the ISACS ARCHIVES.
|
||||
| Sampling Method | Probability Sample | ||||
| Study Population | Subjects admitted with a diagnosis of acute coronary syndromes | ||||
| Condition |
|
||||
| Intervention | Other: Non-interventional patient registry
Non-interventional patient registry
|
||||
| Study Groups/Cohorts |
|
||||
| Publications * | Bugiardini R, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Miličić D, Manfrini O, van der Schaar M, Gale CP, Badimon L, Cenko E. Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease. Hypertension. 2020 Sep;76(3):819-826. doi: 10.1161/HYPERTENSIONAHA.120.15323. Epub 2020 Jul 13. | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status | Recruiting | ||||
| Estimated Enrollment |
130000 | ||||
| Original Estimated Enrollment | Same as current | ||||
| Estimated Study Completion Date | June 28, 2022 | ||||
| Estimated Primary Completion Date | June 28, 2022 (Final data collection date for primary outcome measure) | ||||
| Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
| Sex/Gender |
|
||||
| Ages | 18 Years and older (Adult, Older Adult) | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts |
|
||||
| Listed Location Countries | Italy | ||||
| Removed Location Countries | |||||
| Administrative Information | |||||
| NCT Number | NCT04008173 | ||||
| Other Study ID Numbers | University of Bologna | ||||
| Has Data Monitoring Committee | Yes | ||||
| U.S. FDA-regulated Product |
|
||||
| IPD Sharing Statement |
|
||||
| Responsible Party | Raffaele Bugiardini, University of Bologna | ||||
| Study Sponsor | University of Bologna | ||||
| Collaborators | Not Provided | ||||
| Investigators | Not Provided | ||||
| PRS Account | University of Bologna | ||||
| Verification Date | September 2020 | ||||